Structure Therapeutics GPCR
NASDAQ GPCR
$21.93 -0.08 (-0.36%)
At close: Oct 22, 2026 · 4:00 PM EDT

Structure Therapeutics (GPCR) Net Equity Issued and Repurchased (2022 - 2026)

Updated

Structure Therapeutics (GPCR) posted Net Equity Issued and Repurchased of $1.21 million for Q2 2026, compared with $43,000 a year earlier and up 39.6% from the prior quarter.

Analysis

Structure Therapeutics (GPCR) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Structure Therapeutics was $95.07 million; for FY2025, it was $94 million.

  • Annual Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 44.0% (FY2022 to FY2025).
  • In prior years, Structure Therapeutics' Net Equity Issued and Repurchased was $1.85 million in FY2024 (-99.4%), $300 million in FY2023 (+852.4%) and $31.5 million in FY2022.
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$512.94 million in Q3 2024 to a high of $513.82 million in Q2 2024 over five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in 1 of the last four quarters, with an average decline of 45.5%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $869,000 (Q1 2026), $92.62 million (Q4 2025) and $377,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Structure Therapeutics 4.78 Bn 3.44 Bn - 2.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.09 Mn
Mar 31, 2026 869,000.00
Dec 31, 2025 97.59 Mn
Sep 30, 2025 377,000.00
Jun 30, 2025 517,000.00
Mar 31, 2025 965,000.00
Dec 31, 2024 615,000.00
Sep 30, 2024 -514.18 Mn
Jun 30, 2024 515.29 Mn
Mar 31, 2024 755,000.00
Dec 31, 2023 300.12 Mn
Sep 30, 2023 473,000.00
Jun 30, 2023 179,000.00
Mar 31, 2023 172.33 Mn
Sep 30, 2022 29,000.00
API Access

Structure Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GPCR&period=max&api_key=YOUR_API_KEY